Two Sigma Investments, LP Sensei Biotherapeutics, Inc. Transaction History
Two Sigma Investments, LP
- $40.3 Billion
- Q1 2024
A detailed history of Two Sigma Investments, LP transactions in Sensei Biotherapeutics, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 10,176 shares of SNSE stock, worth $6,309. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,176
Previous 10,176
-0.0%
Holding current value
$6,309
Previous $7,000
42.86%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding SNSE
# of Institutions
27Shares Held
2.32MCall Options Held
0Put Options Held
0-
Newtyn Management, LLC New York, NY930KShares$576,7420.21% of portfolio
-
Vanguard Group Inc Valley Forge, PA574KShares$355,7830.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny211KShares$130,8200.0% of portfolio
-
Geode Capital Management, LLC Boston, MA136KShares$84,5170.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX113KShares$69,9980.0% of portfolio
About Sensei Biotherapeutics, Inc.
- Ticker SNSE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,720,300
- Market Cap $19M
- Description
- Sensei Biotherapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of immunotherapies with an initial focus on treatments for cancer. It develops proprietary ImmunoPhage platform, an immunotherapy approach that is designed to utilize bacteriophage to induce a focused and coordinated innate and adaptive immune res...